Leerink Partnrs Expects Increased Earnings for Veracyte
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Equities researchers at Leerink Partnrs lifted their FY2026 EPS estimates for Veracyte in a report released on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company will post earnings of $0.80 per share for the year, up from their prior estimate of $0.79. […]
Veracyte, Inc. (NASDAQ:VCYT – Free Report) – Equities researchers at Leerink Partnrs lifted their FY2026 EPS estimates for Veracyte in a report released on Monday, April 21st. Leerink Partnrs analyst P. Souda now anticipates that the biotechnology company will post earnings of $0.80 per share for the year, up from their prior estimate of $0.79. […]
